**Question:** Drug of choice for substitution therapy in morphine dependence

**Core Concept:** Morphine is a potent opioid analgesic that binds to μ-opioid receptors in the central nervous system, leading to its therapeutic effects (pain relief) and side effects (euphoria, respiratory depression, and addiction). Substitution therapy aims to reduce harm and dependence while gradually weaning patients off morphine.

**Why the Correct Answer is Right:**

The correct answer is B: Buprenorphine. Buprenorphine is a partial μ-opioid receptor agonist with high affinity and selectivity for these receptors, but has high affinity for κ-opioid receptors as well. This dual binding profile allows for its clinical use in substitution therapy for morphine dependence.

A. Substitution therapy involves replacing morphine with a less harmful opioid. Buprenorphine is a suitable choice due to its partial agonist profile, which reduces the risk of euphoria, respiratory depression, and overdose.

C. Substitution therapy aims to reduce harm and dependence while gradually weaning patients off morphine. Methadone is a full μ-opioid receptor agonist, making it less suitable for substitution therapy.

D. Substitution therapy involves replacing morphine with a less harmful opioid. Methadone is a full μ-opioid receptor agonist, making it less suitable for substitution therapy compared to buprenorphine.

**Why Each Wrong Option is Incorrect:**

A. Methadone (Option C) is a full μ-opioid receptor agonist, which increases the risk of adverse effects like respiratory depression and overdose compared to buprenorphine.

B. Substitution therapy involves replacing morphine with a less harmful opioid. Substitution therapy is not primarily about reducing euphoria; instead, it focuses on reducing the risk of respiratory depression, addiction, and overdose.

C. Substitution therapy involves replacing morphine with a less harmful opioid. Methadone is a full μ-opioid receptor agonist, leading to higher risk of adverse effects compared to buprenorphine.

D. Substitution therapy aims to reduce harm and dependence while gradually weaning patients off morphine. Methadone (Option D) is a full μ-opioid receptor agonist, increasing the risk of adverse effects like respiratory depression and overdose compared to buprenorphine.

**Clinical Pearls:**

1. Substitution therapy with buprenorphine allows for gradual weaning off morphine while minimizing the risk of adverse effects due to its partial agonist profile and κ-opioid receptor antagonist properties.
2. Methadone, as a full μ-opioid receptor agonist, carries higher risks of respiratory depression and overdose compared to buprenorphine.
3. Substitution therapy is a safer and more effective approach to manage morphine dependence as it reduces the risks associated with full μ-opioid receptor agonists like methadone and reduces the risk of respiratory depression and overdose compared to buprenorphine.

**Clinical Pearls:**

-